Exhibit 99.1 

Contact:	Daniel C. Dunn
	Chief Financial Officer
	314/771-2400

Allied Healthcare Products Reports Break-even Quarter

ST. LOUIS, February 13, 2012 – With its markets still facing tight budget constraints, Allied Healthcare Products (NASDAQ: AHPI) reported break-even results for the second quarter of fiscal year 2012.

Net income for the quarter ending December 31, was about $23,000, or zero cents per basic and diluted share, versus $117,000, or 1 cent per basic and diluted share for the prior year. Sales for the quarter declined from about $11.4 million to $10.7 million, or about 6.1 percent, from the previous year.

For the first two quarters of fiscal 2012, net income was a negative $122,000, or a negative 2 cents per basic and diluted share, compared to net income of $29,000, or zero cents per basic and diluted share, for the prior year. Sales for the first two quarters slipped from about $23.3 million to $22.1 million, or about 5.2 percent, from the previous year.

Sales declines in other markets were partially offset by increases in domestic hospital construction and international markets of 12 and 4 percent, respectively, Allied reported.

Increases in costs for commodities such as brass and plastic resin totaled about 8 percent or $110,000 in the first two quarters. Material cost increases were offset by cost reduction projects which reduced manufacturing costs by $160,000 for the two quarters.

“We expect to achieve further cost reductions in operations in the second half of the fiscal year from projects we have underway,” said Earl Refsland, Allied Healthcare Products president and chief executive officer.

Allied Healthcare Products manufactures a variety of respiratory products used in the healthcare industry in a range of hospital and alternate care settings including sub-acute facilities, home healthcare and emergency medical care. Allied product lines include respiratory care products, medical gas equipment and emergency medical products. Allied products are marketed to hospitals, hospital equipment dealers, hospital construction contractors, home healthcare dealers and emergency medical product dealers.

“SAFE HARBOR” STATEMENT: Statements contained in this release that are not historical facts or information are “forward-looking statements.” Words such as “believe,” “expect,” “intend,” “will,” “should,” and other expressions that indicate future events and trends identify such forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause the outcome and future results of operations and financial condition to be materially different than stated or anticipated based on the forward-looking statements. Such risks and uncertainties include both general economic risks and uncertainties, risks and uncertainties affecting the demand for and economic factors affecting the delivery of health care services, and specific matters which relate directly to the Company’s operations and properties as discussed in its periodic filings with the Securities and Exchange Commission. The Company cautions that any forward-looking statement contained in this report reflects only the belief of the Company or its management at the time the statement was made. Although the Company believes such forward-looking statements are based upon reasonable assumptions, such assumptions may ultimately prove inaccurate or incomplete. The Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement was made.

## 

ALLIED HEALTHCARE PRODUCTS, INC.

CONSOLIDATED STATEMENT OF OPERATIONS

(UNAUDITED)

	December 31,						December 31,
	2011			2010			2011			2010
Net sales	$	10,681,395		$	11,402,681		$	22,076,403		$	23,343,414
Cost of sales		7,946,458			8,592,712			16,935,449			17,982,718
Gross profit		2,734,937			2,809,969			5,140,954			5,360,696
Selling General and administrative expenses		2,693,894			2,600,734			5,327,983			5,285,310
Income (loss) from operations		41,043			209,235			(187,029	)		75,386
Interest income		(7,297	)		(8,067	)		(16,292	)		(15,542	)
Interest expense		—			—			336			66
Other, net		11,743			28,410			26,149			43,509
		4,446			20,343			10,193			28,033
Income (loss) before provision for (benefit from) income taxes		36,597			188,892			(197,222	)		47,353
Provision for (benefit from) income taxes		13,907			71,779			(74,944	)		17,994
Net income (loss)	$	22,690		$	117,113		$	(122,278	)	$	29,359
Net income (loss) per share - Basic	$	0.00		$	0.01		$	(0.02	)	$	0.00
Net income (loss) per share - Diluted	$	0.00		$	0.01		$	(0.02	)	$	0.00
Weighted average common shares outstanding - Basic		8,124,386			8,098,366			8,124,386			8,095,876
Weighted average common shares outstanding - Diluted		8,124,834			8,119,386			8,124,386			8,114,724

ALLIED HEALTHCARE PRODUCTS, INC.

CONSOLIDATED BALANCE SHEET

(UNAUDITED)

	December 31, 2011			June 30, 2011
ASSETS
Current assets:
Cash and cash equivalents	$	6,251,364		$	6,512,887
Accounts receivable, net of allowances of $300,000		4,211,786			5,366,860
Inventories, net		11,072,733			10,553,289
Income tax receivable		169,507			95,578
Other current assets		503,979			213,745
Total current assets		22,209,369			22,742,359
Property, plant and equipment, net		8,952,244			8,660,507
Other assets, net		356,359			362,480
Total assets	$	31,517,972		$	31,765,346
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable	$	2,027,981		$	1,644,910
Other accrued liabilities		1,468,468			1,645,552
Deferred income taxes		503,894			512,572
Deferred revenue		458,800			688,200
Total current liabilities		4,459,143			4,491,234
Deferred revenue		—			114,700
Commitments and contingencies
Stockholders' equity:
Preferred stock; $0.01 par value; 1,500,000 shares authorized; no shares issued and outstanding		—			—
Series A preferred stock; $0.01 par value; 200,000 shares authorized; no shares issued and outstanding		—			—
Common stock; $0.01 par value; 30,000,000 shares authorized; 10,427,878 shares issued at December 31, 2011 and June 30, 2011; 8,124,386 shares outstanding at December 31, 2011 and June 30, 2011		104,279			104,279
Additional paid-in capital		48,520,798			48,499,103
Accumulated deficit		(834,820	)		(712,542	)
Less treasury stock, at cost; 2,303,492 shares at
December 31, 2011 and June 30, 2011		(20,731,428	)		(20,731,428	)
Total stockholders' equity		27,058,829			27,159,412
Total liabilities and stockholders' equity	$	31,517,972		$	31,765,346